NIH squashes Synairgen’s COVID therapy from ACTIV-2 trial after omicron shakes up study
NIH squashes Synairgen’s COVID therapy from ACTIV-2 trial after omicron [...]
Athenex cuts jobs, narrows focus to cell therapies in continued fallout from 2021 FDA rejection
Athenex cuts jobs, narrows focus to cell therapies in continued [...]
Sensorion spins hearing loss flop into exploratory win in attempt to revive lead program
Sensorion spins hearing loss flop into exploratory win in attempt [...]
Bridging the preclinical to clinical divide: practical considerations for biomarker success
Bridging the preclinical to clinical divide: practical considerations for biomarker [...]
Shionogi’s COVID-19 antiviral heads to phase 3 backed by NIH after receiving FDA go-ahead
Shionogi’s COVID-19 antiviral heads to phase 3 backed by NIH [...]
MIT-made COVID-19 vax produced by yeast could address global vaccine inequity
MIT-made COVID-19 vax produced by yeast could address global vaccine [...]
FDA’s gene editing guidance is ‘par for the course’ but still important, analysts say
FDA’s gene editing guidance is ‘par for the course’ but [...]
Ovid finds new focus in epilepsy but trims staff to extend cash runway
Ovid finds new focus in epilepsy but trims staff to [...]
Zai Lab hires ex-Lilly CFO who departed after investigation found ‘inappropriate’ behavior
Zai Lab hires ex-Lilly CFO who departed after investigation found [...]
Passage Bio chips away at workforce, prioritizes R&D with UPenn’s James Wilson
Passage Bio chips away at workforce, prioritizes R&D with UPenn’s [...]